--Includes Extensive Data Showing that CM-101, Chemomab's CCL24-Neutralizing Antibody,ย ย Interrupts the Fibro-Inflammatory Processes that Lead to PSC--
Read more at prnewswire.comProvided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.